Taysha's Chief Sold $1.2: What It Means for Investors
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
Understanding what constitutes a good retirement fund at age 40 is essential. Start evaluating your savings for a secure retirement.
15,836 articlesAn insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
LNG demand is reshaping bets on natural gas, lifting producer-focused ETFs while futures-based funds lag. Analysts wa...
Goldman Sachs foresees a trillion-dollar space economy within the next two decades, underpinned by commercial growth ...
A stock surged 125% in 2026, turning heads across the market. This deep-dive breaks down the drivers of the move, how...
When rates rise, many buyers pause. But for seasoned STR investors, higher interest rates turbocharging profits can u...
SpaceX plans to push Starship through another high-stakes test flight. Here’s what investors should watch, how it cou...
Over five years, SPDR’s XLK delivered a 35-point edge on the S&P 500, even as a Feb 2026 pullback tested investor ner...
A new Federal Reserve chair is on the horizon, and markets are keen to know what it means for loans, mortgages, and i...
Looking for biotech growth with real upside? This piece breaks down two innovative biotech stocks that could deliver ...
Healthcare REITs offer income, but they carry unique risks. Learn how to evaluate Medical Properties Trust with actio...
Enterprise Products Partners closed 2025 with record cash flow and a steady ~6% yield, extending a 26-year payout str...
Early 2026 shows Asia-led gains outpacing the U.S., with Asia-focused ETFs rising as tech and earnings momentum impro...